Vaxart, Inc.
Public company- Headquarters
- SOUTH SAN FRANCISCO, California
- Industry
- Biotechnology
- Ticker
- VXRT
- CIK
- 0000072444
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Oct 19, 2026
Executive appointmentmember of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| member of the BoardRaquel C. Bono, M.D., M.B.A., FACS | Oct 19, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Cardiff Oncology, Inc.
CMO appointed: Leila Alland
- Caribou Biosciences, Inc.
Plant closure: Berkeley, CA
- Executive appointment
member of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
Raquel C. Bono, M.D., M.B.A., FACS was named member of the Board of Vaxart, Inc., effective October 16, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 19, 2026Role: member of the Board
Only one public record so far. We add events as soon as a new filing lands; watch Vaxart, Inc. to get them in your digest.
Last verified Nov 8, 2026